ACZ885 in Type 1 Diabetes Mellitus

NCT01322321 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus
Diabetes Type 1

Interventions

DRUG: ACZ885
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals